Literature DB >> 30272855

Untargeted metabolomics approach (UPLC-Q-TOF-MS) explores the biomarkers of serum and urine in overweight/obese young men.

Hai-Tao Yu1, Xiao-Yi Fu1, Bin Xu1, Li-Li Zuo1, Hong-Bo Ma1, Shu-Ran Wang2.   

Abstract

BACKGROUND AND OBJECTIVES: Obesity is linked to metabolic diseases characterized by insulin resistance, such as diabetes and cardiovascular disease. In this study, we investigated the metabolic disorders of uncomplicated obesity to identify early alterations in biological systems. METHODS AND STUDY
DESIGN: Metabolic differences between overweight/obese (n=36) and normal-weight (n=35) young Chinese men without known metabolic disorders were assessed. Metabolic profiling of the serum and urine was performed using ultra-performance liquidchromatography quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Partial least squares discriminant analysis (PLS-DA) was undertaken to reveal and classify the differences between the two groups.
RESULTS: Compared to normal-weight men, obese men had higher levels of the serum metabolites phenylalanine, Phe-Phe, and L-tryptophan, whereas those of p-cresol sulfate and p-cresol were less in obesity. Urinary metabolites phenylacetamide, L-glutamine, phenylacetylglutamine, indoxyl sulfate, p-cresol, and p-cresol sulfate were greater in obese men.
CONCLUSIONS: These findings indicate that disorders involving aromatic amino acids and the tricarboxylic acid cycle (TCA) have microbiomic involvement in the uncomplicated phase of obesity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272855     DOI: 10.6133/apjcn.052018.07

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  7 in total

Review 1.  Metabolomics prospect of obesity and metabolic syndrome; a systematic review.

Authors:  Moloud Payab; Akram Tayanloo-Beik; Khadijeh Falahzadeh; Maryamossadat Mousavi; Saeede Salehi; Shirin Djalalinia; Mahbube Ebrahimpur; Nafiseh Rezaei; Mostafa Rezaei-Tavirani; Bagher Larijani; Babak Arjmand; Kambiz Gilany
Journal:  J Diabetes Metab Disord       Date:  2021-11-26

2.  Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies.

Authors:  Oscar Daniel Rangel-Huerta; Belén Pastor-Villaescusa; Angel Gil
Journal:  Metabolomics       Date:  2019-06-13       Impact factor: 4.290

3.  Metabolic footprint of aging and obesity in red blood cells.

Authors:  Inés Domingo-Ortí; Rubén Lamas-Domingo; Andreea Ciudin; Cristina Hernández; José Raúl Herance; Martina Palomino-Schätzlein; Antonio Pineda-Lucena
Journal:  Aging (Albany NY)       Date:  2021-02-19       Impact factor: 5.682

4.  Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children.

Authors:  Rocío Quiroga; Esther Nistal; Brisamar Estébanez; David Porras; María Juárez-Fernández; Susana Martínez-Flórez; María Victoria García-Mediavilla; José A de Paz; Javier González-Gallego; Sonia Sánchez-Campos; María J Cuevas
Journal:  Exp Mol Med       Date:  2020-07-06       Impact factor: 8.718

5.  A diagnostic model for overweight and obesity from untargeted urine metabolomics of soldiers.

Authors:  Exsal M Albores-Mendez; Alexis D Aguilera Hernández; Alejandra Melo-González; Marco A Vargas-Hernández; Neptalí Gutierrez de la Cruz; Miguel A Vazquez-Guzman; Melchor Castro-Marín; Pablo Romero-Morelos; Robert Winkler
Journal:  PeerJ       Date:  2022-07-22       Impact factor: 3.061

Review 6.  A Scoping Review: Metabolomics Signatures Associated with Animal and Plant Protein Intake and Their Potential Relation with Cardiometabolic Risk.

Authors:  Gaïa Lépine; Hélène Fouillet; Didier Rémond; Jean-François Huneau; François Mariotti; Sergio Polakof
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

7.  Plasma Metabolomic Profiling in 1391 Subjects with Overweight and Obesity from the SPHERE Study.

Authors:  Gianfranco Frigerio; Chiara Favero; Diego Savino; Rosa Mercadante; Benedetta Albetti; Laura Dioni; Luisella Vigna; Valentina Bollati; Angela Cecilia Pesatori; Silvia Fustinoni
Journal:  Metabolites       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.